138 related articles for article (PubMed ID: 22250639)
1. Sequential therapy in plaque psoriasis using the " Hit and Run " approach: infliximab followed by efalizumab.
Penz S; Pelletier F; Riou-Gotta MO; Puzenat E; Levang J; Mermet I; Humbert P; Aubin F
Int J Dermatol; 2012 Feb; 51(2):236-7. PubMed ID: 22250639
[No Abstract] [Full Text] [Related]
2. Efalizumab rebound response to a sequential therapy of infliximab followed by efalizumab.
Brunasso AM; Delfino C; Massone C
Dermatology; 2009; 218(1):73-4. PubMed ID: 18841002
[No Abstract] [Full Text] [Related]
3. Infliximab-induced remission of extensive plaque psoriasis.
Amital H; Ingber A; Rubinow A
Isr Med Assoc J; 2003 Nov; 5(11):827-8. PubMed ID: 14650114
[No Abstract] [Full Text] [Related]
4. Successful treatment of recalcitrant palmoplantar pustular psoriasis with sequential use of infliximab and adalimumab.
Yawalkar N; Hunger RE
Dermatology; 2009; 218(1):79-83. PubMed ID: 18974629
[No Abstract] [Full Text] [Related]
5. Infliximab then efalizumab, the 'hit and run' approach does not work.
Barde C; Thielen AM; Saurat JH
Dermatology; 2008; 216(2):171-2. PubMed ID: 18216482
[TBL] [Abstract][Full Text] [Related]
6. Striking and rapid improvement of plaque psoriasis with infliximab. A report of two cases.
Al-Salem IH
Dermatology; 2003; 207(1):54-6. PubMed ID: 12835550
[TBL] [Abstract][Full Text] [Related]
7. Effective management of psoriasis symptom worsening during efalizumab therapy without discontinuing treatment: a case study.
Gisondi P; Giglio MD; Girolomoni G
J Dermatolog Treat; 2006; 17(3):172-5. PubMed ID: 16854760
[TBL] [Abstract][Full Text] [Related]
8. Infliximab for the treatment of psoriasis in the U.K.: 9 years' experience of infusion reactions at a single centre.
Wee JS; Petrof G; Jackson K; Barker JN; Smith CH
Br J Dermatol; 2012 Aug; 167(2):411-6. PubMed ID: 22404545
[TBL] [Abstract][Full Text] [Related]
9. Use of infliximab in the treatment of psoriasis.
Lee MR; Cooper AJ
Australas J Dermatol; 2004 Aug; 45(3):193-5. PubMed ID: 15250904
[No Abstract] [Full Text] [Related]
10. Long-term durability and dose escalation patterns in infliximab therapy for psoriasis.
Luber AJ; Tsui CL; Heinecke GM; Lebwohl MG; Levitt JO
J Am Acad Dermatol; 2014 Mar; 70(3):525-32. PubMed ID: 24388425
[TBL] [Abstract][Full Text] [Related]
11. Long-term management of generalized pustular psoriasis with infliximab: case series.
Routhouska SB; Sheth PB; Korman NJ
J Cutan Med Surg; 2008; 12(4):184-8. PubMed ID: 18627699
[TBL] [Abstract][Full Text] [Related]
12. Treatment of inverse psoriasis with efalizumab.
George D; Rosen T
J Drugs Dermatol; 2009 Jan; 8(1):74-6. PubMed ID: 19180901
[TBL] [Abstract][Full Text] [Related]
13. Combination therapy of infliximab and ciclosporin in the treatment of recalcitrant psoriasis: a case series.
Martinez-Mera C; Camarero-Mulas C; Sanz-Sánchez T; Daudén E
Br J Dermatol; 2017 Mar; 176(3):803-805. PubMed ID: 27943238
[No Abstract] [Full Text] [Related]
14. Addition of low-dose methotrexate to infliximab in the treatment of a patient with severe, recalcitrant pustular psoriasis.
Barland C; Kerdel FA
Arch Dermatol; 2003 Jul; 139(7):949-50. PubMed ID: 12873907
[No Abstract] [Full Text] [Related]
15. Efficacy and safety of infliximab vs. methotrexate in patients with moderate-to-severe plaque psoriasis: results of an open-label, active-controlled, randomized trial (RESTORE1).
Barker J; Hoffmann M; Wozel G; Ortonne JP; Zheng H; van Hoogstraten H; Reich K
Br J Dermatol; 2011 Nov; 165(5):1109-17. PubMed ID: 21910713
[TBL] [Abstract][Full Text] [Related]
16. Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial.
Reich K; Nestle FO; Papp K; Ortonne JP; Evans R; Guzzo C; Li S; Dooley LT; Griffiths CE;
Lancet; 2005 Oct 15-21; 366(9494):1367-74. PubMed ID: 16226614
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of severe recalcitrant psoriasis with combination infliximab and methotrexate.
Kirby B; Marsland AM; Carmichael AJ; Griffiths CE
Clin Exp Dermatol; 2001 Jan; 26(1):27-9. PubMed ID: 11260172
[TBL] [Abstract][Full Text] [Related]
18. Infliximab treatment for psoriasis in 120 patients on therapy for a minimum of one year: a review.
Kamili QU; Miner A; Hapa A; Menter A
J Drugs Dermatol; 2011 May; 10(5):539-44. PubMed ID: 21533302
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of alefacept, efalizumab, etanercept and infliximab in treating moderate to severe plaque psoriasis: a meta-analysis of randomized controlled trials.
Brimhall AK; King LN; Licciardone JC; Jacobe H; Menter A
Br J Dermatol; 2008 Aug; 159(2):274-85. PubMed ID: 18547300
[TBL] [Abstract][Full Text] [Related]
20. Psoriasis and its treatment with infliximab-mediated tumor necrosis factor alpha blockade.
Winterfield L; Menter A
Dermatol Clin; 2004 Oct; 22(4):437-47, ix. PubMed ID: 15450339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
